Literature DB >> 8309691

[Knee joint function and the cruciate ligaments. Biomechanical principles for reconstruction and rehabilitation].

N F Friederich1.   

Abstract

Trauma to the knee joint with disruption of one or both cruciate ligaments will start a biological response: inflammatory reactions, neurophysiological changes due to disruption of afferent nerve endings, and biomechanical changes which will ultimately lead to instability (functional and mechanical) as well as to early degenerative changes. Treatment, whether operative or non-operative, has to be based on a sound knowledge of biological and biomechanical principles. Cruciate ligament graft positioning, fixation, pre-tensioning, operative technique for reconstruction, and rehabilitation will all have influence on each other. All these factors therefore have to be balanced to achieve good mid- to long-term results.

Entities:  

Mesh:

Year:  1993        PMID: 8309691

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  5 in total

Review 1.  [Posterior knee instability].

Authors:  F Hoffman
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

2.  [Intraoperative quality control of the placement of bone tunnels for the anterior cruciate ligament].

Authors:  H H Pässler; J Höher
Journal:  Unfallchirurg       Date:  2004-04       Impact factor: 1.000

Review 3.  [Ligaments of the knee].

Authors:  R Putz; H Mühlhofer; Y Ercan
Journal:  Orthopade       Date:  2007-07       Impact factor: 1.087

Review 4.  Complex function of the knee joint: the current understanding of the knee.

Authors:  Michael T Hirschmann; Werner Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-12       Impact factor: 4.342

5.  Transportal central femoral tunnel placement has a significantly higher revision rate than transtibial AM femoral tunnel placement in hamstring ACL reconstruction.

Authors:  Mark Clatworthy; Steffen Sauer; Tim Roberts
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-07-12       Impact factor: 4.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.